: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
please enter a valid email address
.
your current city: mumbai
..
�the kind of review being proposed does not, at least initially, appear to bring anything new or needed to is already a robust system of oversight,� mogulof said in the statement..